Randomized controlled trial of treatment expectation and intravenous fluid in pediatric migraine

Headache

Volumn 54, Issue 9, 2014, Pages 1496-1505

  Richer, Lawrence ^a,b   Craig, William ^a,b   Rowe, Brian ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

^b The Women's and Children's Health Research Institute   (Canada)

Author keywords

migraine; pediatric; treatment expectation

Indexed keywords

ANTIMIGRAINE AGENT; DIPHENHYDRAMINE; INFUSION FLUID; KETOROLAC; METOCLOPRAMIDE;

ADOLESCENT; ANALGESIA; ARTICLE; CHILD; CHILDHOOD DISEASE; CLINICAL ARTICLE; CLINICAL PROTOCOL; CONTROLLED STUDY; DEMOGRAPHY; EMERGENCY WARD; EXPECTATION; FEMALE; FLUID THERAPY; FOLLOW UP; HUMAN; MALE; MIGRAINE; PATIENT SATISFACTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RECURRENT DISEASE; SINGLE BLIND PROCEDURE; TREATMENT EXPECTATION; TREATMENT OUTCOME;

EID: 85027954213     PISSN: 00178748     EISSN: 15264610     Source Type: Journal    
DOI: 10.1111/head.12443     Document Type: Article

References (21)

1. Kernick D, Campbell J,. Measuring the impact of headache in children: A critical review of the literature. Cephalalgia. 2009; 29: 3-16.
2. El-Chammas K, Keyes J, Thompson N, Vijayakumar J, Becher D, Jackson JL,. Pharmacologic treatment of pediatric headaches: A meta-analysis. JAMA Pediatr. 2013; 167: 250-258.
3. Richer LP, Graham L, Klassen T, Rowe B,. Emergency department management of acute migraine in children in Canada: A practice variation study. Headache. 2007; 47: 703-710.
4. Richer LP, Laycock K, Millar K, et al. Treatment of children with migraine in emergency departments: National practice variation study. Pediatrics. 2010; 126: e150-e155.
5. Brousseau DC, Duffy SJ, Anderson AC, Linakis JG,. Treatment of pediatric migraine headaches: A randomized, double-blind trial of prochlorperazine versus ketorolac. Ann Emerg Med. 2004; 43: 256-262.
6. Cortelli P, Montagna P,. Migraine as a visceral pain. Neurol Sci. 2009; 30 (Suppl. 1): S19-S22.
7. Zubieta J-K, Stohler CS,. Neurobiological mechanisms of placebo responses. Ann N Y Acad Sci. 2009; 1156: 198-210.
8. Headache Classification Subcommittee of the International Headache Society. The International Classification of Headache Disorders: 2nd edition. Cephalalgia. 2004; 24 (Suppl. 1): 9-160.
9. Hicks CL, von Baeyer CL, Spafford PA, van Korlaar I, Goodenough B,. The Faces Pain Scale-Revised: Toward a common metric in pediatric pain measurement. Pain. 2001; 93: 173-183.
10. Lee JS, Hobden E, Stiell IG, Wells GA,. Clinically important change in the visual analog scale after adequate pain control. Acad Emerg Med. 2003; 10: 1128-1130.
11. Powell CV, Kelly AM, Williams A,. Determining the minimum clinically significant difference in visual analog pain score for children. Ann Emerg Med. 2001; 37: 28-31.
12. Canadian Institutes of Health Research, Natural Sciences Engineering Research Council of Canada, Social Sciences Humanities Research Council of Canada. Tri-Council Policy Statement: Ethical Conduct for Research Involving Humans. 2010. pp. 1-204.
13. Lewis DW, Winner P, Wasiewski W,. The placebo responder rate in children and adolescents. Headache. 2005; 45: 232-239.
14. Macedo A, Farre M, Banos JE,. A meta-analysis of the placebo response in acute migraine and how this response may be influenced by some of the characteristics of clinical trials. Eur J Clin Pharmacol. 2006; 62: 161-172.
15. Evers S, Marziniak M, Frese A, Gralow I,. Placebo efficacy in childhood and adolescence migraine: An analysis of double-blind and placebo-controlled studies. Cephalalgia. 2009; 29: 436-444.
16. Enck P, Benedetti F, Schedlowski M,. New insights into the placebo and nocebo responses. Neuron. 2008; 59: 195-206.
17. International Headache Society Clinical Trials Subcommittee members, Tfelt-Hansen P, Pascual J, et al. Guidelines for controlled trials of drugs in migraine: Third edition. A guide for investigators. Cephalalgia. 2012; 32: 6-38.
18. Friedman BW, Bijur PE, Lipton RB,. Standardizing emergency department-based migraine research: An analysis of commonly used clinical trial outcome measures. Acad Emerg Med. 2010; 17: 72-79.
19. Trottier ED, Bailey B, Dauphin-Pierre S, Gravel J,. Clinical outcomes of children treated with intravenous prochlorperazine for migraine in a pediatric emergency department. J Emerg Med. 2010; 39: 166-173.
20. Aurora SK, Dodick DW, Turkel CC, et al. OnabotulinumtoxinA for treatment of chronic migraine: Results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 1 trial. Cephalalgia. 2010; 30: 793-803.
21. Diener HC, Dodick DW, Aurora SK, et al. OnabotulinumtoxinA for treatment of chronic migraine: Results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 2 trial. Cephalalgia. 2010; 30: 804-814.